from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2908c/-

LFCtreatmentdescriptionclass of inhibitor

2.457

Amikacinug/mL Amikacintranslation

1.921

Cap5-10ug/mL Capreomycintranslation

2.859

Rox10-50 ug/mL Roxithromycintranslation

1.251

SM2-5 ug/mL Streptomycintranslation

3.581

Tet5-10 ug/mL Tetracyclinetranslation

-0.074

Rif0.2-5ug/mL Rifampicintranscription

0.376

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.235

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.237

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.658

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.793

Clofazimine10-13 ug/mL Clofaziminerespiration

0.121

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.567

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.232

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.003

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.084

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.935

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.444

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.922

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.559

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.516

KCN5-20 ug/mL Potassium cyaniderespiration

-0.449

NaN30.2-2 mM Sodium aziderespiration

0.499

Nigericin50 uM Nigericinrespiration

-0.320

TRC10-150 ug/mL Triclosanrespiration

-1.386

TRZ10-25 ug/mL Thioridazinerespiration

0.345

Valinomycin0.5-10 uM Valinomycinrespiration

-0.232

ZnSO42 mM ZnSO4respiration

-0.584

menadione6-10 ug/mL Menadionerespiration

0.152

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.552

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.375

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.299

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.436

NRP_1Non-replicating persistence stage 1dosRassociated

0.584

Amp0.2mg/mL AmpicillincellWall

0.372

Cephalexin20-100 ug/mL CephalexincellWall

0.620

Cerulenin0.32-5 ug/mL CerulenincellWall

0.400

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.121

EMB10-20 ug/mL EthambutolcellWall

0.421

Eta12-40 ug/mL EthionamidecellWall

0.667

INH0.2-0.4 ug/mL IsoniazidcellWall

0.442

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.159

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.535

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.240

BZA0.12 mg/mL BenzamidearomaticAmides

-0.277

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.268

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.238

H2O24 mM hydrogen peroxideDNAdamaging

0.289

Levo10 ug/mL LevofloxacinDNAdamaging

0.622

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.573

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.427

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.594

UVUV-irradiationDNAdamaging

-0.873

ARP41-4 ug/mL Antitubercular compound ARP4?

0.498

Antimycin12.5-50 ug/mL Antimycin A?

0.208

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.277

PA_110-50 ug/mL Antitubercular compound PA-1?

0.216

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.255

PA8240.2-2 ug/mL PA-824?

-0.687

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.209

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.040

Verapamil50 uM Verapamil?

0.023

mercaptoethanol2 mM 2-Mercaptoethanol?

0.316

methoxatin10-20 ug/mL Methoxatin?